Transcription of Pharmaceuticals in the Environment
{{id}} {{{paragraph}}}
11 Pharmaceuticals in the EnvironmentAs a responsible healthcare company, we are committed to the health and safety of our society and planet. We make it a priority to effectively manage the risks associated with Pharmaceuticals in the Environment (PIE).2 Pharmaceuticals enter the environmental mainly as a result of patient use, where they can pass through our bodies and into waterways. Drug manufacture and the improper disposal of unused medicines also add to the trace levels of Pharmaceuticals in rivers, lakes, soils, and, sometimes, drinking water. AstraZeneca recognises that, even in such low concentrations, the risks associated with Pharmaceuticals in the Environment (PIE) should be determined, minimised and managed.
risk assess and manage emissions associated with the APIs they manufacture or formulate on our behalf. These values are described in Appendix 2. We have an annual review programme to confirm compliance with these safe discharge concentrations. From 2009–2011 we conducted a comprehensive site effluent project, which measured API effluent
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}